Table 1.
Typical clinical features and symptoms suggesting the presence of systemic mastocytosis (SM)* or a mast cell activation syndrome
| Feature/symptom | Typical laboratory findings |
|---|---|
| Anaphylaxis with hypotension | Allergy tests (specific IgE) negative |
| Severe anaphylactic shock after hymenoptera venom exposure** | Allergy tests positive or negative and: tryptase elevated during the event** |
| Headache plus diarrhea responsive to histamine receptor antagonists | increased histamine levels (plasma, urine), tryptase may or may not increase |
| Unexplained pruritus (+/- urticaria or flushing) responsive to histamine receptor antagonists | no skin disease, allergy, or internal disorder explaining symptoms are found, tryptase may or may not increase |
| Other allergy-like symptoms that are responsive to histamine receptor antagonists or mast cell-targeting drugs (like cromolyn) | no allergy and no other disease explaining the symptoms are found, tryptase may or may not increase |
| Bone pain due to osteopenia or osteoporosis*** | T score below -2 (below -2.5) as assessed by age-adjusted osteodensitometry |
if two or more of these features/symptoms are recorded in the same patient, the likelihood increases that the patient is suffering from SM.
meeting the criteria of mast cell activation syndrome (MCAS).
counts especially in man, and when other causes of osteoporosis have been excluded.